HQ-355
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C16H13FN2O |
| Molar mass | 268.291 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
HQ-355, is an analogue of the sedative and hypnotic drug methaqualone developed in the late 1970s. It is a derivative of methaqualone substituted with a fluorine on the 2-methyl group. It has similar effects to methaqualone in animal studies but with slightly higher potency and an improved side effect profile. HQ-355 itself was never developed for medical uses, but its 6-amino derivative afloqualone did pass human trials and has seen some limited clinical application as a muscle relaxant.[1][2][3]
See also
References
- ^ Ager IR, Harrison DR, Kennewell PD, Taylor JB (March 1977). "Synthesis and central nervous system activity of quinazolones related to 2-methyl-3-(o-tolyl)-4(3H)-quinazolone (methaqualone)". Journal of Medicinal Chemistry. 20 (3): 379–386. doi:10.1021/jm00213a013. PMID 845871.
- ^ Tani J, Yamada Y, Oine T, Ochiai T, Ishida R, Inoue I (January 1979). "Studies on biologically active halogenated compounds. 1. Synthesis and central nervous system depressant activity of 2-(fluoromethyl)-3-aryl-4(3H)-quinazolinone derivatives". Journal of Medicinal Chemistry. 22 (1): 95–99. doi:10.1021/jm00187a021. PMID 423189.
- ^ Ochiai T, Ishida R, Nurimoto S, Inoue I, Kowa Y (June 1972). "Pharmacology of a new hypnotic drug: HQ-355". Japanese Journal of Pharmacology. 22 (3): 431–434. doi:10.1254/jjp.22.431. PMID 4539402.